INmune Bio (INMB) Metrics: History & Chart

INmune Bio, Inc.(INMB)

Biotechnology · Boca Raton, FL

$1.84-0.10 (-5.41%)

Delayed quote: Oct 6, 2026, 3:39 PM EDT

About INmune Bio, Inc.

INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies. Its primary objective is to harness the body's innate immune system to combat various illnesses. The company is actively engaged in developing and bringing to market therapeutic candidates designed to address a spectrum of conditions such as blood cancers, solid tumors, and chronic inflammatory diseases. Its pipeline features key development programs including: INKmune: Aimed at treating women suffering from relapsed or refractory ovarian carcinoma and individuals diagnosed with high-risk myelodysplastic syndrome. INB03: An immunotherapy targeting patients with both hematologic malignancies and solid tumors. XPro1595: Under development for the treatment of Alzheimer's disease. INmune Bio holds licensing agreements with entities including Xencor, Inc., Immune Ventures, LLC, the University of Pittsburgh, and University College London. Established in 2015, INmune Bio is headquartered in Boca Raton, Florida.

Boca Raton, FL

21 employees

www.inmunebio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David J. Moss

View full financials

Third-Party DCF Estimate (FMP)	$0.77
Price Gap vs Third-Party Estimate	-60.51%

7D Total Return	-3.00%
30D Total Return	-20.49%
YTD Total Return	+24.36%
1Y Total Return	-6.73%
3Y Total Return	-71.56%
5Y Total Return	-89.98%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+24.36%
2025	-66.60%
2024	-58.53%
2023	+77.60%
2022	-37.84%
2021	-40.77%
2020

CAGR TTM	-6.70%
CAGR 3Y	-34.23%
CAGR 5Y	-36.88%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

INMB Valuation Metrics

INMB Stock Price Metrics

INMB Dividend Metrics

INMB Growth Rate Metrics

INMB Discounted Cash Flow Metrics

INMB Returns By Period

INMB Yearly Returns

INMB Average Annual Returns By Period (CAGR)

INMB Revenue Metrics

INMB PE Ratio Metrics

INMB PS Ratio Metrics

INMB PB Ratio Metrics

INMB Price to Free Cash Flow Ratio Metrics

INMB Debt to Equity Ratio Metrics

INMB PEG Ratio Metrics

INMB FCF Yield

INMB Earnings Yield

INMB EBITDA Yield

INMB OCF Yield

INMB EV/EBIT Ratio Metrics

INMB EV/EBITDA Ratio Metrics

INMB EV/Assets Ratio Metrics

INMB EV/Sales Ratio Metrics

INMB Current Ratio Metrics

INMB Quick Ratio Metrics

INMB ROIC Metrics

INMB Return on Assets Metrics

INMB Return on Equity Metrics

INMB Net Profit Margin Metrics

INMB Gross Profit Margin Metrics

INMB Tax Rate Metrics

PS Ratio	760.34
PS Ratio Avg TTM	885.37
PS Ratio Avg 3Y	980.58
Current VS TTM Avg	-14.12%
Current VS 3Y Avg	-22.46%
Current VS 5Y Avg	-43.29%

PB Ratio	2.55
PB Ratio Avg TTM	1.94
PB Ratio Avg 3Y	3.26
Current VS TTM Avg	+31.67%
Current VS 3Y Avg	-21.85%
Current VS 5Y Avg	-9.95%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.07
Debt/Equity Ratio Avg TTM	0.05
Debt/Equity Ratio Avg 3Y	0.13
Current VS TTM Avg	+39.07%
Current VS 3Y Avg	-45.07%
Current VS 5Y Avg	-58.81%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	21.86
Ev/Ebitda Ratio Avg TTM	29.85
Ev/Ebitda Ratio Avg 3Y	29.85
Current VS TTM Avg	-26.77%
Current VS 3Y Avg	-26.77%
Current VS 5Y Avg	-26.77%

Ev/Assets Ratio	1.30
Ev/Assets Ratio Avg TTM	0.70
Ev/Assets Ratio Avg 3Y	1.76
Current VS TTM Avg	+84.57%
Current VS 3Y Avg	-26.26%
Current VS 5Y Avg	-13.55%

Ev/Sales Ratio	286.00
Ev/Sales Ratio Avg TTM	345.26
Ev/Sales Ratio Avg 3Y	724.20
Current VS TTM Avg	-17.16%
Current VS 3Y Avg	-60.51%
Current VS 5Y Avg	-70.80%

Current Ratio	4.04
Current Ratio Avg TTM	4.04
Current Ratio Avg 3Y	3.23
Current VS TTM Avg	+0.05%
Current VS 3Y Avg	+25.05%
Current VS 5Y Avg	-33.66%

Quick Ratio	4.04
Quick Ratio Avg TTM	4.04
Quick Ratio Avg 3Y	3.23
Current VS TTM Avg	+0.05%
Current VS 3Y Avg	+25.05%
Current VS 5Y Avg	-33.66%

ROIC	(96.37%)
ROIC Avg 3Y	(122.85%)
ROIC Avg 5Y	(88.63%)
Current VS 3Y Avg	+21.55%
Current VS 5Y Avg	-8.74%
Current VS 10Y Avg	-91.74%

ROA	(68.60%)
ROA Avg TTM	(25.25%)
ROA Avg 3Y	(17.77%)
Current VS TTM Avg	-171.66%
Current VS 3Y Avg	-286.14%
Current VS 5Y Avg	-384.98%

ROE	(90.44%)
ROE Avg TTM	(177.31%)
ROE Avg 3Y	(128.85%)
Current VS TTM Avg	+48.99%
Current VS 3Y Avg	+29.81%
Current VS 5Y Avg	+5.86%

Net Profit Margin	(91866.00%)
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	(6962.76%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	-1219.39%
Current VS 5Y Avg	-941.72%

Gross Profit Margin	100.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	38.46%
Current VS TTM Avg	N/A
Current VS 3Y Avg	+160.00%
Current VS 5Y Avg	+75.00%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A